"Welcome to Lakes Region General Hospital (LRGH). Our mission is to provide quality, compassionate care and to strengthen the well-being of our community. LRGH is a community and regional acute care facility with a licensed bed capacity of 132 beds. We offer a comprehensive range of medical, surgical, diagnostic, occupational and rehabilitative services, as well as community health and wellness education programs. We are committed to providing a network of dedicated physicians and providers, supported by the highest quality of services to meet all of your family's healthcare needs."

During the past decade, LRGHealthcare-Lakes Region General Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 58 clinical trials were completed, i.e. on average, 580% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 23 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LRGHealthcare-Lakes Region General Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 30 trials, followed by "National Cancer Institute (NCI)" with 24 trials sponsored, "SWOG Cancer Research Network" with 15 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LRGHealthcare-Lakes Region General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 54 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "LRGHealthcare-Lakes Region General Hospital" are "Breast Cancer" (15 trials), "Lung Cancer" (7 trials), "Colorectal Cancer" (6 trials), "Recurrent Squamous Cell Lung Carcinoma" (6 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials). Many other conditions were trialed in "LRGHealthcare-Lakes Region General Hospital" in a lesser frequency.

Most popular intervention types in "LRGHealthcare-Lakes Region General Hospital" are "Drug" (66 trials), "Other" (52 trials), "Biological" (27 trials), "Radiation" (7 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "placebo" (15 trials), "Bevacizumab" (8 trials), "Docetaxel" (7 trials) and "Paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "LRGHealthcare-Lakes Region General Hospital" are 56 trials for "All" genders, 19 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "LRGHealthcare-Lakes Region General Hospital". undefined are not yet recruiting, 3 are recruiting, 23 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in LRGHealthcare-Lakes Region General Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in LRGHealthcare-Lakes Region General Hospital, 3 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".